Gland Pharma Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹1,742.79 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.80 per cent from ₹1,695.36 crore. This corresponds to a year-on-year *(YoY) growth of 22.31 per cent.
Operating Profit
Operating Profit stands at ₹513.02 crore, reflecting a quarter-on-quarter *(QoQ) increase of 24.97 per cent from ₹410.53 crore. This corresponds to a year-on-year *(YoY) growth of 47.62 per cent.
PBDT
PBDT stands at ₹614.46 crore, reflecting a quarter-on-quarter *(QoQ) increase of 30.80 per cent from ₹469.78 crore. This corresponds to a year-on-year *(YoY) growth of 59.98 per cent.
Profit Before Tax
Profit Before Tax stands at ₹505.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 39.67 per cent from ₹362.13 crore. This corresponds to a year-on-year *(YoY) growth of 75.42 per cent.
Net Profit
Net Profit stands at ₹366.68 crore, reflecting a quarter-on-quarter *(QoQ) increase of 40.23 per cent from ₹261.48 crore. This represents a 96.57 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Gland Pharma Ltd News
Gland Pharma Ltd Earnings
- YOY
- QOQ
Gland Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Gland Pharma Ltd Research Reports
Gland Pharma Ltd Financial Reports
Gland Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Gland Pharma | -1.12% | 1.47% | 3.63% | 40.79% | 37.79% | 30.53% |
| Ipca Labs. | 5.03% | 0.30% | -0.76% | 12.99% | 24.05% | 27.48% |
| Glaxosmi. Pharma | -2.95% | -1.65% | 6.91% | 5.87% | 3.25% | -5.36% |
| Ajanta Pharma | -2.19% | 0.17% | 1.89% | 11.05% | 20.43% | 35.11% |
| Emcure Pharma | 0.03% | 3.20% | 7.59% | 18.73% | 30.02% | 38.68% |
| Wockhardt | -0.40% | 5.71% | 5.23% | 17.18% | 44.15% | 36.50% |
| Sai Life | 2.13% | 6.00% | 13.04% | 29.20% | 64.12% | 75.74% |
Company Info
Company Information
Chairman / Executive Director / MD / CEO : SRINIVAS SADU
Independent Non Exe. Director : UDO JAHANNES VETTER
Independent Non Exe. Director : ESSAJI GOOLAM VAHANVATI
Non-Exec & Non-Independent Dir : Jia Ai (Allen) Zhang
Independent Non Exe. Director : Naina Lal Kidwai
Non-Exec & Non-Independent Dir : Wenjie Zhang
Non-Exec & Non-Independent Dir : Wei Huang
CS / Compliance Officer / Vice President : SAMPATH KUMAR PALLERLAMUDI
Additional Director : William Robert Keller